AZD6738 reverses the LPS-induced corneal inflammatory transcriptional program through a conserved transcription factor network converging on NF-κB
5 affiliations
- 1Department of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
- 2Department of Ophthalmology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China
- 3Fujian Institute of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
- 4Fujian Provincial Clinical Medical Research Center of Eye Diseases and Optometry, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
- 5Department of Ophthalmology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Abstract
BackgroundVision loss in bacterial keratitis arises primarily from the host inflammatory response rather than the infection itself, and antimicrobial resistance narrows the benefit achievable with antibiotics alone. AZD6738, an inhibitor of ataxia telangiectasia and Rad3-related kinase (ATR), suppresses lipopolysaccharide (LPS)- induced corneal inflammation in mice, but the transcriptional basis of this effect is uncharacterized.MethodsMice received intrastromal LPS injection and were assigned to control (CTL), LPS and AZD6738-treated (ATRi) groups (n = 3 each). Corneas harvested at 48 h were analyzed by RNA sequencing with DESeq2-based differential expression, KEGG enrichment, regression-based reversal quantification and TRRUST v2 regulon gene set enrichment analysis (GSEA). Cross-species conservation was assessed in a human bacterial keratitis transcriptome (GSE241715; 4 cases, 7 controls). In RAW264.7 macrophages, p65-3 × Flag overexpression with LPS stimulation tested the effect of AZD6738 on NF-κB-driven transcription and Ser536 phosphorylation; tolerability was assessed in HCE-T corneal epithelial cells.ResultsLPS upregulated 1,622 and downregulated 140 corneal genes (padj <0.05, |log2FC| > 1), enriched in 80 immune-related pathways. Regression of the treatment effect on the LPS effect indicated reversal of approximately 57% of LPS-induced changes, and 51.2% of LPS-upregulated genes were significantly reversed. Regulon analysis defined an inflammatory transcription factor (TF) program spanning NF-κB, IRF, STAT, AP-1 and myeloid families; cross-species normalized enrichment score (NES) values were rank-correlated (Spearman ρ = 0.62, n = 214, P = 3.4 × 10−24). NFKB1, RELA, SPI1 and STAT1 were significant in both species, and AZD6738 shifted their regulon activity to negative values (NES −2.81 to −2.56). In p65-overexpressing RAW264.7 cells, AZD6738 reduced NF-κB-driven transcription and Ser536 phosphorylation.ConclusionsAZD6738 reverses a substantial part of the LPS-induced corneal inflammatory transcriptome and suppresses an inflammatory TF program whose regulons are conserved in human bacterial keratitis, supporting ATR inhibition as an adjunct to antimicrobial therapy in bacterial keratitis.
Related
- Nicotinamide Mononucleotide Is Associated with Attenuation of OGD/R-Induced Pro-Inflammatory Programs in Microglia: Transcriptomic Evidence Converging on the NLRP3 Inflammasome and Lipid-Droplet-Related Molecular Signatures
- Targeting SUV39H2 exon skipping reverses resistance to CDK4/6 inhibitors via transcriptional activation of p21
- Single-cell transcriptome analysis highlights conserved transcriptional responses across multiple models of Retinitis Pigmentosa
- Systematic pathway‐level analysis defines conserved transcriptional divergence between primary lung tumors and cell line models
- A conserved EREG+IL1RN+ macrophage program defines an inflammation-associated transcriptional state linked to WTAP reprogramming and preterm premature rupture of membranes
BibTeX
@article{ye2026azd6738,
title = {{AZD6738 reverses the LPS-induced corneal inflammatory transcriptional program through a conserved transcription factor network converging on NF-κB}},
author = {Qin Ye and Qin Ye and Qin Ye and Qin Ye and Kaiping Chen and Kaiping Chen and Kaiping Chen and Kaiping Chen and Longxiang Huang and Longxiang Huang and Longxiang Huang and Longxiang Huang and Yinqi Chen and Da Chen and Da Chen and Da Chen and Da Chen and Biting Zhou and Biting Zhou and Biting Zhou and Biting Zhou and Yihua Zhu and Yihua Zhu and Yihua Zhu and Yihua Zhu},
journal = {Frontiers in Medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2026.2005671},
url = {https://doi.org/10.3389/fmed.2026.2005671},
note = {CC BY},
}
RIS
TY - JOUR
TI - AZD6738 reverses the LPS-induced corneal inflammatory transcriptional program through a conserved transcription factor network converging on NF-κB
AU - Qin Ye
AU - Qin Ye
AU - Qin Ye
AU - Qin Ye
AU - Kaiping Chen
AU - Kaiping Chen
AU - Kaiping Chen
AU - Kaiping Chen
AU - Longxiang Huang
AU - Longxiang Huang
AU - Longxiang Huang
AU - Longxiang Huang
AU - Yinqi Chen
AU - Da Chen
AU - Da Chen
AU - Da Chen
AU - Da Chen
AU - Biting Zhou
AU - Biting Zhou
AU - Biting Zhou
AU - Biting Zhou
AU - Yihua Zhu
AU - Yihua Zhu
AU - Yihua Zhu
AU - Yihua Zhu
PY - 2026
DA - 2026/10/26
JO - Frontiers in Medicine
DO - 10.3389/fmed.2026.2005671
UR - https://doi.org/10.3389/fmed.2026.2005671
AB - BackgroundVision loss in bacterial keratitis arises primarily from the host inflammatory response rather than the infection itself, and antimicrobial resistance narrows the benefit achievable with antibiotics alone. AZD6738, an inhibitor of ataxia telangiectasia and Rad3-related kinase (ATR), suppresses lipopolysaccharide (LPS)- induced corneal inflammation in mice, but the transcriptional basis of this effect is uncharacterized.MethodsMice received intrastromal LPS injection and were assigned to control (CTL), LPS and AZD6738-treated (ATRi) groups (n = 3 each). Corneas harvested at 48 h were analyzed by RNA sequencing with DESeq2-based differential expression, KEGG enrichment, regression-based reversal quantification and TRRUST v2 regulon gene set enrichment analysis (GSEA). Cross-species conservation was assessed in a human bacterial keratitis transcriptome (GSE241715; 4 cases, 7 controls). In RAW264.7 macrophages, p65-3 × Flag overexpression with LPS stimulation tested the effect of AZD6738 on NF-κB-driven transcription and Ser536 phosphorylation; tolerability was assessed in HCE-T corneal epithelial cells.ResultsLPS upregulated 1,622 and downregulated 140 corneal genes (padj <0.05, |log2FC| > 1), enriched in 80 immune-related pathways. Regression of the treatment effect on the LPS effect indicated reversal of approximately 57% of LPS-induced changes, and 51.2% of LPS-upregulated genes were significantly reversed. Regulon analysis defined an inflammatory transcription factor (TF) program spanning NF-κB, IRF, STAT, AP-1 and myeloid families; cross-species normalized enrichment score (NES) values were rank-correlated (Spearman ρ = 0.62, n = 214, P = 3.4 × 10−24). NFKB1, RELA, SPI1 and STAT1 were significant in both species, and AZD6738 shifted their regulon activity to negative values (NES −2.81 to −2.56). In p65-overexpressing RAW264.7 cells, AZD6738 reduced NF-κB-driven transcription and Ser536 phosphorylation.ConclusionsAZD6738 reverses a substantial part of the LPS-induced corneal inflammatory transcriptome and suppresses an inflammatory TF program whose regulons are conserved in human bacterial keratitis, supporting ATR inhibition as an adjunct to antimicrobial therapy in bacterial keratitis.
SN - 2296-858X
ER -